Hyderabad based
During the quarter, export sales of Lenalidomide product to
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
982.9 INR | -0.71% | -0.21% | +21.14% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Hyderabad based
During the quarter, export sales of Lenalidomide product to
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+21.14% | 2.12B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |